(MNPR) Monopar Therapeutics - Performance 1167.3% in 12m
Compare MNPR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
4.85%
#35 in Group
Rel. Strength
99.97%
#3 in Universe
Total Return 12m
1167.27%
#2 in Group
Total Return 5y
13.03%
#39 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
61th Percentile in Group
12m Total Return: MNPR (1167.3%) vs XBI (-1.8%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
| HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
| AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
| LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
| KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
| ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: MNPR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MNPR
| Total Return (including Dividends) | MNPR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 14.86% | 2.28% | -0.87% |
| 3 Months | -4.82% | -10.48% | -7.58% |
| 12 Months | 1167.27% | -1.83% | 11.88% |
| 5 Years | 13.03% | -12.72% | 110.33% |
| Trend Score (consistency of price movement) | MNPR | XBI | S&P 500 |
| 1 Month | 79.1% | 56.6% | 23% |
| 3 Months | -25.0% | -89.3% | -88.5% |
| 12 Months | 88.6% | -42.4% | 55.1% |
| 5 Years | -54.7% | -53.6% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #59 | 12.3% | 15.9% |
| 3 Month | #62 | 6.32% | 2.98% |
| 12 Month | #2 | 1,191% | 1,033% |
| 5 Years | #38 | 29.5% | -46.3% |
FAQs
Does MNPR Monopar Therapeutics outperforms the market?
Yes,
over the last 12 months MNPR made 1167.27%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months MNPR made -4.82%, while XBI made -10.48%.
Over the last 3 months MNPR made -4.82%, while XBI made -10.48%.
Performance Comparison MNPR vs Indeces and Sectors
MNPR vs. Indices MNPR is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.73% | 15.7% | 189% | 1,155% |
| US NASDAQ 100 | QQQ | -3.76% | 13.5% | 188% | 1,155% |
| US Dow Jones Industrial 30 | DIA | -1.79% | 18.0% | 189% | 1,158% |
| German DAX 40 | DAX | -1.50% | 13.5% | 169% | 1,143% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.23% | 17.7% | 192% | 1,161% |
| Hongkong Hang Seng | HSI | -1.74% | 14.8% | 187% | 1,153% |
| India NIFTY 50 | INDA | 0.11% | 10.8% | 189% | 1,164% |
| Brasil Bovespa | EWZ | -1.93% | 10.3% | 185% | 1,173% |
MNPR vs. Sectors MNPR is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.98% | 15.9% | 183% | 1,143% |
| Consumer Discretionary | XLY | -2.81% | 15.0% | 186% | 1,154% |
| Consumer Staples | XLP | 0.77% | 14.7% | 184% | 1,156% |
| Energy | XLE | 1.75% | 28.7% | 195% | 1,178% |
| Financial | XLF | -1.34% | 17.0% | 181% | 1,145% |
| Health Care | XLV | -2.65% | 18.7% | 191% | 1,166% |
| Industrial | XLI | -3.15% | 14.8% | 188% | 1,158% |
| Materials | XLB | -2.12% | 17.3% | 196% | 1,171% |
| Real Estate | XLRE | -1.21% | 16.2% | 190% | 1,149% |
| Technology | XLK | -5.18% | 13.2% | 192% | 1,160% |
| Utilities | XLU | 0.11% | 14.8% | 187% | 1,145% |
| Aerospace & Defense | XAR | -3.68% | 8.47% | 175% | 1,141% |
| Biotech | XBI | -4.03% | 12.6% | 202% | 1,169% |
| Homebuilder | XHB | -2.04% | 17.1% | 204% | 1,174% |
| Retail | XRT | -1.16% | 15.4% | 194% | 1,170% |